KEQU
Kewaunee Scientific Corporation
KEQU's fundamentals are mixed, but it looks expensive: trading at 13x earnings, above its usual 11x.
KEQU Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Strong |
KEQU's balance sheet is currently strong, and its revenue and profitability are stable, but its cash flow is under pressure.
KEQU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.5x | $20.79 | -42% |
| Fair | 11x | $29.03 | -19% |
| Expensive | 13x | $36.49 | +1.5% |
| Current | 13x | $35.94 | — |
Historical ranges are pointers, not guarantees.
KEQU's PE is in its expensive range at 13x.
KEQU Forward outlook
There aren't enough analyst estimates for KEQU to show an outlook.
KEQU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.76 | -33% |
| Q2 2026 | $3.22 | -16% |
| Q1 2026 | $3.72 | -37% |
| Q4 2025 | $3.94 | -38% |
| Q3 2025 | $4.13 | -34% |
| Q2 2025 | $3.83 | -40% |
| Q1 2025 | $5.94 | +98% |
| Q4 2024 | $6.34 | +164% |
KEQU's earnings per share have fallen from their peak: $2.76 over the past year, against $6.38 in early 2024.
KEQU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $66.3M | -6.7% |
| Q2 2026 | $71.4M | -7.5% |
| Q1 2026 | $69.4M | +3.3% |
| Q4 2025 | $70.1M | +47% |
| Q3 2025 | $71.1M | +47% |
| Q2 2025 | $77.1M | +36% |
| Q1 2025 | $67.2M | +44% |
| Q4 2024 | $47.8M | -5.3% |
KEQU's revenue is growing: $66M last quarter, down 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.8% | -2 points |
| Q2 2026 | 7.3% | -3.7 points |
| Q1 2026 | 3.7% | +0.4 points |
| Q4 2025 | 5.9% | -3.4 points |
| Q3 2025 | 6.8% | +1.4 points |
| Q2 2025 | 11% | +1.2 points |
| Q1 2025 | 3.4% | -4.8 points |
| Q4 2024 | 9.3% | -0.9 points |
KEQU's operating margin was 4.8% last quarter, down 2 points from the same quarter a year ago.
KEQU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2M | -76% |
| Q2 2026 | $4.5M | -49% |
| Q1 2026 | $11M | +$13.9M |
| Q4 2025 | -$5.8M | -175% |
| Q3 2025 | $5M | +$6.1M |
| Q2 2025 | $8.9M | +5256% |
| Q1 2025 | -$3M | -133% |
| Q4 2024 | $7.8M | +$8.3M |
KEQU generated $11M in free cash flow over the past year, down 42% from the year before.
KEQU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | -1.3x | Net Cash |
KEQU's net debt is less than a year of its operating earnings (EBITDA).
KEQU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.8 | Neutral |
| Stochastic | 35.7 | Neutral |
KEQU's weekly RSI is 51 (neutral) and its Stochastic is 36 (neutral).
KEQU PE vs Consumer Cyclical Sector
| Metric | KEQU | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 28% below |
| PE % | 81 | 47 | 34 pts above |
KEQU is trading at 13x earnings, a 28% discount to the Consumer Cyclical sector's median of 18x.
KEQU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.9 | 6% above |
| 20 week MA | $35.4 | 1.5% above |
| 50 week MA | $37.0 | 2.9% below |
| 100 week MA | $42.5 | 15% below |
| 200 week MA | $35.1 | 2.4% above |
KEQU's trend is mixed: it's above three of its five weekly moving averages, and 2.4% above its 200-week average.
KEQU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.1 | $10.6 | -19% |
| 2021 | $10.6 | $12.3 | +16% |
| 2022 | $12.3 | $15.8 | +28% |
| 2023 | $15.8 | $29.1 | +85% |
| 2024 | $29.1 | $63.8 | +120% |
| 2025 | $63.8 | $38.0 | -40% |
| 2026 YTD | $38.0 | $35.9 | -5.4% |
KEQU's yearly returns have swung widely, from +120% in 2024 to −40% in 2025. It's down 5.4% so far in 2026.